Human BioSciences, Inc. USA的封面图片
Human BioSciences, Inc. USA

Human BioSciences, Inc. USA

生物技术研究

Gaithersburg,MD 5,534 位关注者

Producing biotechnology advancements in Kollagen? wound products for safe, simple, effective use in Humans & Animals.

关于我们

Human BioSciences (HBS) Inc. is a specialty biotechnology company focused on developing collagen in wound care management. HBS is an integral worldwide developer, manufacturer, and distributor of advanced wound care products, including collagen sheets, particles and gels popularly known as SkinTemp? II Dressings, Medifil? II Particles and Collatek? Gel for Human Use. Kollavet? Products include collage sheets, particles and gel for veterinary use. The headquarters and main production facility is located in Gaithersburg, Maryland. They also have one factory in Ahmedabad, India. It is FDA-compliant and ISO 13485 certified. HBS products are approved to manage burns, scrapes, sores, ulcers, acute and chronic wounds from superficial to deep injuries. Easy application and product compatibility with topical agents and dressings allow product use in a myriad of applications. Human products are currently available with a prescription in clinics, healthcare facilities, and doctor's offices. OTC product line available on Amazon for Animal Use and coming soon for humans. For more information and access to products please contact [email protected] or [email protected].

网站
www.humanbiosciences.com
所属行业
生物技术研究
规模
11-50 人
总部
Gaithersburg,MD
类型
私人持股
领域
Advanced Wound Care、wound care、collagen、private label、manufacturing、biotechnology、brand、education和Distributor

地点

Human BioSciences, Inc. USA员工

动态

  • The Future of Wound Care is Here! Artificial Intelligence is transforming wound assessment—providing more accurate diagnoses, personalized treatment plans, and improved healing outcomes. With AI-powered tools, healthcare professionals can deliver smarter, faster, and more effective care. Precision. Personalization. Faster Healing. The future of healing starts now. Learn more at the profile. #WoundCareInnovation #AIinHealthcare #SmartHealing #FutureOfMedicine #EveryWoundMatters #HumanBioSciences

    • 该图片无替代文字
    • 该图片无替代文字
  • The Future of Wound Care Starts Here At?Human BioSciences, we are revolutionizing wound healing with our groundbreaking?Kollagen? technology. By preserving the natural integrity of?100% non-hydrolyzed native bovine collagen, we ensure superior stability, enhanced tissue regeneration, and faster healing. This advanced approach sets a new standard in wound management, offering healthcare professionals a powerful tool for treating a wide range of wounds. Discover how Kollagen? technology is changing the future of wound care.

  • Discover the future of advanced wound care with our flagship products! Swipe through to explore how Medifil accelerates tissue regeneration, SkinTemp enhances skin’s natural balance, and Collatek delivers precise wound management. At Human BioSciences, every wound matters—because innovative healing is our promise. Learn more: www.humanbiosciences.com #EveryWoundMatters #WoundCareInnovation #Medifil #SkinTemp #Collatek #HumanBioSciences

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • At Human BioSciences, our 30?year journey has been defined by groundbreaking innovations and a relentless commitment to advanced wound care. Today, as we look ahead, our vision is clear: to expand our reach, innovate relentlessly, and forge global partnerships that ensure every wound receives the best possible care. Global Partnerships for Expanding Impact Our strategic direction is not only defined by internal innovation but also by our commitment to collaboration. By forging new partnerships around the world, we plan to extend the reach of our advanced wound care solutions to communities that need them most. Our Commitment: Every Wound Matters Our core belief is simple yet profound: every patient matters, and every wound matters. This principle drives our every decision, from research and development to global outreach. A Call to Join Our Journey The future of wound care is dynamic and full of promise. At Human BioSciences, we are excited to continue our legacy of innovation and leadership. We invite healthcare professionals, research partners, and industry leaders to join us on this journey. Together, we can shape the future of wound care and ensure that every wound, regardless of its severity or location, receives the dedicated care it deserves. Learn more about our vision and future initiatives at www.humanbiosciences.com.

  • At the heart of our journey is a commitment to lead by example. Our leadership not only drives our growth but also shapes industry trends by continuously challenging the status quo. By fostering a culture of innovation and collaboration, we empower healthcare professionals to elevate patient care, one breakthrough at a time. #LeadershipInsights #InnovationInHealthcare #EveryWoundMatters #WoundCare #HumanBioSciences

    • 该图片无替代文字
  • The Story of Human BioSciences: 30 Years of Innovation In the early 1990s, wound care was a world of limited options—wet-to-dry dressings made of simple cotton gauze were the norm. That all changed when our visionary founder, Dr. Manoj K Jain, made a groundbreaking discovery: the preservation of the collagen molecule. Recognizing its untapped potential, Dr. Jain pioneered a method that not only formed the foundation of our business but also revolutionized the entire advanced wound care industry. In 1991, the FDA cleared our Kollagen? products, marking a turning point in wound care. For the first time, healthcare professionals could interact directly with wounds and actively influence the healing process. As these innovative products proved their value over the next decade, clinicians’ positive feedback reached the highest levels of healthcare policy. The Department of Health and Human Services established a new category of Medicare reimbursement codes for collagen, validating our approach and paving the way for further collagen-based innovations. Remarkably, it took ten years after our initial launch for any competitor to receive FDA clearance for a collagen product. Today, collagen has become the standard for wound care, and Kollagen? stands as the gold standard in collagen technology. Our 30?year journey is a testament to innovation, resilience, and our unwavering commitment to ensuring that every wound matters. Join us as we continue to innovate and lead in wound care. Learn more about our journey and explore our legacy at www.humanbiosciences.com.

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • Regulatory Updates in Wound Care – What You Need to Know The wound care industry is witnessing significant regulatory changes that are reshaping product development, clinical practices, and compliance standards. Staying informed about these updates is essential for healthcare professionals, manufacturers, and stakeholders. In this article, we explore the latest regulatory shifts, how they impact the industry, and what steps you can take to remain at the forefront of innovation. Recent updates from regulatory bodies, such as the FDA and European Medicines Agency (EMA), have introduced stricter standards for wound care products. These changes emphasize improved safety protocols, enhanced clinical evidence, and rigorous quality control measures. Companies are now required to provide comprehensive clinical data to support product claims, ensuring that only the most effective and safe wound care solutions reach the market. For healthcare professionals, these regulatory updates mean access to products that have undergone more stringent evaluation processes. Enhanced guidelines aim to reduce the risk of complications and improve overall patient outcomes. As a result, clinicians can have greater confidence in the products they use, knowing that they meet high standards of efficacy and safety. At Human BioSciences, we have always prioritized excellence and compliance. Our innovative collagen-based solutions are developed in accordance with the latest regulatory standards, ensuring that our products not only meet but exceed industry requirements. By embracing these changes, we continue to provide healthcare professionals with advanced, reliable solutions that support optimal wound care. Regulatory updates in wound care are paving the way for improved safety and better clinical outcomes. Staying current with these changes is crucial for all industry stakeholders. At Human BioSciences, we are committed to leading this evolution with products backed by science, compliance, and a passion for better healing. Stay informed and partner with us as we navigate these regulatory advancements together. Learn more about our commitment to quality and innovation at www.humanbiosciences.com.

    • 该图片无替代文字

相似主页

查看职位